Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 2
1993 4
1994 4
1995 3
1996 6
1998 3
1999 1
2001 3
2002 1
2016 1
2020 2
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Incidences of Deep Molecular Responses and Treatment-Free Remission in de Novo CP-CML Patients.
Etienne G, Dulucq S, Bauduer F, Adiko D, Lifermann F, Dagada C, Lenoir C, Schmitt A, Klein E, Madene S, Fort MP, Bijou F, Moldovan M, Turcq B, Robbesyn F, Durrieu F, Versmée L, Katsahian S, Faberes C, Lascaux A, Mahon FX. Etienne G, et al. Among authors: faberes c. Cancers (Basel). 2020 Sep 4;12(9):2521. doi: 10.3390/cancers12092521. Cancers (Basel). 2020. PMID: 32899879 Free PMC article.
Relevance of treatment-free remission recommendations in chronic phase chronic leukemia patients treated with frontline tyrosine kinase inhibitors.
Etienne G, Faberes C, Bauduer F, Adiko D, Lifermann F, Dagada C, Lenoir C, Schmitt A, Klein E, Fort MP, Bijou F, Turcq B, Robbesyn F, Durrieu F, Versmée L, Madene S, Moldovan M, Katsahian S, Charles-Nelson A, Lascaux A, Mahon FX, Dulucq S. Etienne G, et al. Among authors: faberes c. Cancer Med. 2021 Jun;10(11):3635-3645. doi: 10.1002/cam4.3921. Epub 2021 May 14. Cancer Med. 2021. PMID: 33988316 Free PMC article.
A single center evaluation of cost savings related to treatment-free remission in chronic myeloid leukemia patients: the prerequisites of a pharmaco-economy larger study.
Etienne G, Dulucq S, Faberes C, Bijou F, Schmitt A, Klein E, Fort MP, Durrieu F, Toulza E, Mahon FX. Etienne G, et al. Among authors: faberes c. Br J Haematol. 2020 May;189(3):e97-e100. doi: 10.1111/bjh.16511. Epub 2020 Feb 10. Br J Haematol. 2020. PMID: 32043283 Free article. No abstract available.
Sexual quality of life is impaired in patients with chronic hepatitis C.
Vergniol J, Duc S, Hou G, Hiriart JB, Foucher J, Chenus F, Fabères C, Chermak F, Lafournière A, Souakri N, de Lédinghen V. Vergniol J, et al. Among authors: faberes c. Int J Impot Res. 2016 Mar-Apr;28(2):68-73. doi: 10.1038/ijir.2016.5. Epub 2016 Feb 11. Int J Impot Res. 2016. PMID: 26865102
Autografting in chronic myeloid leukemia: an overview.
Reiffers J, Mahon FX, Boiron JM, Fabères C, Marit G, Cony-Makhoul P, Broustet A. Reiffers J, et al. Among authors: faberes c. Leukemia. 1996 Mar;10(3):385-8. Leukemia. 1996. PMID: 8642851 Review.
Autologous peripheral-blood progenitor-cell support following high-dosechemotherapy or chemoradiotherapy in patients with high-risk multiple myeloma.
Marit G, Faberes C, Pico JL, Boiron JM, Bourhis JH, Brault P, Bernard P, Foures C, Cony-Makhoul P, Puntous M, Vezon G, Broustet A, Girault D, Reiffers J. Marit G, et al. Among authors: faberes c. J Clin Oncol. 1996 Apr;14(4):1306-13. doi: 10.1200/JCO.1996.14.4.1306. J Clin Oncol. 1996. PMID: 8648388 Clinical Trial.
32 results